Kurum Yazarı "Mercan, Rıdvan" PubMed İndeksli Yayın Koleksiyonu İçin Listeleme
-
Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data
Kimyon, G.; Kalyoncu, U.; Kiraz, S.; Beş, C.; Coşkun, N.; Yağız, B.; Ertenli, I; Mercan, Rıdvan (Clinical & Exper Rheumatology, 2021)Objective To determine the real-life efficacy, safety, and drug-retention rates of leflunomide (LEF) or methotrexate (MTX) as a synthetic DMARD used in combination with biological DMARDs for rheumatoid arthritis (RA). ... -
Biological and targeted-synthetic disease-modifying antirheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: Real-life TReasure prospective data
Kimyon, G.; Kalyoncu, Umut; Kiraz, Sedat; Bes, Cemal; Coşkun, Necdet; Yagiz, B.; Kelesoglu, B.; Mercan, Rıdvan (Clinical and Experimental Rheumatology S.A.S., 2021)Objective To determine the real-life efficacy, safety, and drug-retention rates of leflunomide (LEF) or methotrexate (MTX) as a synthetic DMARD used in combination with biological DMARDs for rheumatoid arthritis (RA). ... -
Cardiovascular disease risk prediction in scleroderma
Çelikkol, Aliye; Mercan, Rıdvan; Güzel, Savaş; Yılmaz, Ahsen (Assoc Medica Brasileira, 2023)OBJECTIVE: Cardiovascular disease risk prediction in scleroderma is important. In this study of scleroderma patients, the aim was to investigate the relationship between cardiac myosin-binding protein-C, sensitive troponin ... -
Clinical and laboratory factors associated with bamboo spine in patients with axial spondyloarthritis: are there clues for bamboo spine?
Atagündüz, P.; Kiraz, S.; Akar, S.; Küçükşahin, O.; Erden, A.; Aksoy, A.; Coşkun, B.N.; Mercan, Rıdvan (Clinical and Experimental Rheumatology S.A.S., 2023)Objective To analyse the clinical and laboratory factors associated with bamboo spine. Methods Data of patients fulfilling the 2009 ASAS classification criteria for axial spondyloarthritis, registered in the national, ... -
Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data from the Psoriatic Arthritis-International Database
Bilgin, E.; Aydın, S. Z.; Tinazzi, Ilaria; Bayındır, Özün; Kimyon, G.; Özişler, Cem; Kalyoncu, Umut; Mercan, Rıdvan (Clinical & Exper Rheumatology, 2021)Objective To explore the impact of early versus late-onset psoriasis (PsO) on the disease characteristics of psoriatic arthritis (PsA) in a large-multicentre cohort. Methods The data from a multicentre psoriatic arthritis ... -
Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: Cross-sectional data from the psoriatic arthritis-international database
Bilgin, E.; Aydın, S.Z.; Tinazzi, I.; Bayındır, Ö.; Kimyon, G.; Özişler, C.; Kalyoncu, Umut; Mercan, Rıdvan (Clinical and Experimental Rheumatology S.A.S., 2021)Objective To explore the impact of early versus late-onset psoriasis (PsO) on the disease characteristics of psoriatic arthritis (PsA) in a large-multicentre cohort. Methods The data from a multicentre psoriatic arthritis ... -
The effect of long-term systemic immunosuppressive drug use on druse formation: a new perspective to age-related macular degeneration
Sever, Özkan; Mercan, Rıdvan (Tubitak Scientific & Technical Research Council Turkey, 2020)Background/aim: To evaluate the effect of the long-term use of systemic immunosuppressive drugs on druse formation in patients aged over 50 years. Materials and methods: The current retrospective cohort study includes 420 ... -
Enthesitis may be one of the signs of severe disease in familial Mediterranean fever
Şen, Nesrin; Yılmaz, Mesut; Mercan, Rıdvan; Volkan, Ömür; Yılmaz Öner, Sibel; Tükel, Ezgi; Tezcan, Mehmet Engin (Springer London Ltd, 2021)Objective Familial Mediterranean fever (FMF) is an auto-inflammatory disease that is also characterized with some of the common musculoskeletal features of spondyloarthritis (SpA). Enthesitis is the hallmark of SpA. Recently, ... -
Evaluation of Asymptomatic Bacteriuria and Urinary Tract Infection in Patients With Primary Sjögren's Syndrome
Çetin, Zeynep; Mercan, Rıdvan; Karasahin, Omer; Tufan, Abdurrahman; Öztürk, Mehmet Akif (Turkish League Against Rheumatism, 2020)Objectives: This study aims to determine the frequency and risk factors of bacteriuria and urinary tract infection (UTI) in patients with primary Sjogren's syndrome (SS) and their differences from healthy individuals and ... -
Familial Mediterranean Fever Patients may have Unmet Needs for the Treatments of Exertional Leg Pain and Enthesitis
Tezcan, Mehmet Engin; Volkan, Ömür; Mercan, Rıdvan; Şen, Nesrin; Yılmaz Öner, Sibel (Ediciones Doyma, S.L., 2021)Introduction: Exertional leg pain (ELP) and enthesitis are musculoskeletal findings in familial Mediterranean fever (FMF). They are not accepted as principal treatment targets. In this study, we assessed the effectiveness ... -
Familial mediterranean fever patients may have unmet needs for the treatments of exertional leg pain and enthesitis
Tezcan, Mehmet Engin; Volkan, Ömür; Mercan, Rıdvan; Şen, Nesrin; Yılmaz-Öner, Sibel (Elsevier Espana Slu, 2022)Introduction: Exertional leg pain (ELP) and enthesitis are musculoskeletal findings in familial Mediterranean fever (FMF). They are not accepted as principal treatment targets. In this study, we assessed the effectiveness ... -
The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database
Kanıtez, Nilüfer Alpay; Kiraz, Sedat; Dalkılıç, Ediz; Kimyon, Gezmiş; Mercan, Rıdvan; Karadağ, Ömer; Beş, Cemal; Mercan, Rıdvan (Aves, 2022)Objective: The coronavirus disease 2019 pandemic has been resulting in increased hospital occupancy rates. Rheumatic patients cannot still reach to hospitals, or they hesitate about going to a hospital even they are able ... -
In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
Yağız, Burcu; Coşkun, Belkıs Nihan; Pehlivan, Yavuz; Dalkılıç, Ediz; Kiraz, Sedat; Yazısız, Veli; Kalyoncu, Umut; Mercan, Rıdvan (Springer Heidelberg, 2021)We wanted to see how close we could get to our goal of treating rheumatoid arthritis (RA) without the use of glucocorticoids (GCs) in the disease-modifying antirheumatic drugs (DMARDs) era using real-life data. Established ... -
Methodology of a new inflammatory arthritis registry: TReasure
Kalyoncu, Umut; Tascilar, Etem Koray; Ertenli, Ali İhsan; Dalkılıç, Hüseyin Ediz; Bes, Cemal; Küçükşahin, Orhan; Kiraz, Sedat; Mercan, Rıdvan (Tubitak Scientific & Technical Research Council Turkey, 2018)Background/aim: The TReasure registry, created in 2017, is an observational multicenter cohort that includes inflammatory arthritis patients. This article reviews the methodology and objectives of the TReasure registry ... -
Next-generation screening of a panel of genes associated with periodic fever syndromes in patients with Familial Mediterranean Fever and their clinical characteristics
Bozgeyik, Esra; Mercan, Rıdvan; Arslan, A.; Tozkır, Hilmi (Academic Press Inc., 2020)Familial Mediterranean Fever (FMF) is a hereditary fever syndrome that primarily affects Mediterranean populations. For the study, total number of 182 patients with FMF disease were enrolled and screening of a panel of ... -
Physicians' Biological Drug Preference in Patients With Rheumatoid Arthritis and Spondyloarthritis With a History of Malignancy: Perspectives From the Treasure Database
Tekgöz, Emre; Çolak, Seda; Yardımcı, Kübra G.; Küçükşahin, Orhan; Çınar, Muhammet; Yılmaz, Sedat; Kalyoncu, Umut; Mercan, Rıdvan (NLM (Medline), 2022)OBJECTIVE: Because of concerns about malignancy risks, using biological disease-modifying antirheumatic drugs (bDMARDs) in patients with a history of malignancy remains a challenging issue in rheumatology practice. This ... -
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic
Kalyoncu, Umut; Pehlivan, Yavuz; Akar, Servet; Kaşifoğlu, Timuçin; Kimyon, G.; Karadağ, Ö.; Kiraz, Sedat; Mercan, Rıdvan (Turkiye Klinikleri, 2021)Background/aim: To evaluate treatment adherence and predictors of drug discontinuation among patients with inflammatory arthritis receiving bDMARDs within the first 100 days after the announcement of the COVID-19 pandemic. ... -
PsART-ID inception cohort: clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis
Ayan, Gizem; Aydın, Sibel Zehra; Kimyon, Gezmiş; Özişler, Cem; Tinazzi, Ilaria; Doğru, Atalay; Yazisiz, Veli; Mercan, Rıdvan (Oxford Univ Press, 2021)Objectives. Our aim is to understand clinical characteristics, real-life treatment strategies, outcomes of early PsA patients and determine the differences between the inception and established PsA cohorts. Methods. PsArt-ID ... -
Psoriasis and family history of psoriasis may not affect disease severity of rheumatoid arthritis
Şen, Nesrin; Mercan, Rıdvan; Geçmez, G.; Ediz, B.; Volkan, Ömür; Yılmaz Öner, Sibel; Tezcan, Mehmet Engin (Pagepress Publ, 2021)The incidence of psoriasis in patients with rheumatoid arthritis (RA) is higher than in the general population. In addition, psoriasis may negatively affect the severity of rheumatological diseases in patients with ... -
Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry
Aydın, Sibel Zehra; Kimyon, Gezmiş; Özişler, Cem; Tarhan, Emine Figen; Gunal, Esen Kasapoglu; Kücük, Adem; Kalyoncu, Umut; Mercan, Rıdvan (Aves, 2020)Objective: Our aim is to test the validity of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome, to assess the psoriasis severity within the scope of rheumatology. Methods: Within the PsA international ...